ArticleVeterinary research communications2025
Minimum reporting guidelines for platelet-rich plasma in veterinary regenerative medicine.
Article in Veterinary research communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Design Strategies to Target Joint Resident Mesenchymal Stem Cells for Osteochondral Regeneration.Cells · 2026Review
- Anti-Inflammatory and Metabolic Effects of Fresh Versus Freeze-Dried Platelet-Rich Plasma on Equine Osteoarthritis in an Ex Vivo Cartilage-Synovium Explant Co-Culture System: A Pilot Study.Veterinary sciences · 2026Article
- The Use of Platelet-Rich Plasma in Wildlife Veterinary Medicine.Animals : an open access journal from MDPI · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Platelet concentrates such as platelet-rich plasma (PRP) are widely used in veterinary regenerative medicine and transfusion therapy. However, the therapeutic efficacy of PRP is highly dependent on its precise characterization, cellular composition, and preparation methods. Without proper standardization, PRP treatments can yield inconsistent results, undermining their clinical utility. A recent study in Veterinary Research Communications underscores the importance of pH measurement as a key quality control parameter for platelet concentrates, including PRP, in veterinary blood banks. Building on these findings and our own recent experience, we propose revised minimum reporting guidelines for the use of PRP in veterinary regenerative medicine. Adherence to minimum reporting guidelines is essential to ensure reproducibility and reduce heterogeneity in PRP therapies. Future research should focus on species-specific protocols and advanced characterization techniques to enhance the therapeutic potential of PRP. By addressing these challenges, PRP can become a cornerstone of regenerative therapies in veterinary medicine, offering safe and effective treatment options for various diseases and disorders.
Indexed as
Identifiers
39985602What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.